EVH — Evolent Health, Inc.
—
NYSE ·
Unknown ·
Unknown ·
CIK 1628908 ·
Last close
$3.09
Market Cap
$347.57M
52W High
$6.26
52W Low
$2.95
ADV30
3,222,227
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 496,246,000 | 83,774,000 | -10,599,000 | -26,632,000 | 1,878,847,000 | 142,028,000 | 1,482,454,000 |
| Dec 2025 | 468,719,000 | 97,253,000 | -20,440,000 | -429,131,000 | 1,899,236,000 | 151,856,000 | 1,484,042,000 |
| Sep 2025 | 479,533,000 | 99,774,000 | -1,433,000 | -20,864,000 | 2,453,459,000 | 116,650,000 | 1,611,226,000 |
| Jun 2025 | 444,328,000 | 100,385,000 | 2,035,000 | -19,897,000 | 2,461,532,000 | 150,995,000 | 1,565,527,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$38,843,000
Investing CF
$-91,545,000
Financing CF
$-35,924,000
CapEx
$-34,088,000
Dividends Paid
$-11,127,000
Buybacks
$0
EPS Diluted TTM
$-5.15
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,315,327,000
Inventory
—
Receivables
$309,861,000
ST Investments
—
EBIT TTM
$-476,011,000
Pretax Income TTM
$-534,636,000
Interest Exp TTM
$58,625,000
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,888,825,984
EBITDA
$74,355,000
Free Cash Flow
$52,930,624
Enterprise Value
$1,201,086,848
Total Cash
$142,028,000
Total Debt
$985,425,024
Shares Out
112,481,067
Trailing EPS
$-4.68
Book Value
$3.52
ROE
-65.1%
ROA
-0.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,876,229,000 | -19,834,000 | -534,510,000 | 1,899,236,000 | 1,484,042,000 | — | 38,843,000 |
| Dec 2024 | 2,554,741,000 | -14,067,000 | -61,623,000 | 2,544,411,000 | 1,543,152,000 | — | 18,765,000 |
| Dec 2023 | 1,963,896,000 | -21,055,000 | -113,040,000 | 2,680,308,000 | 1,612,607,000 | — | 142,582,000 |
| Dec 2022 | 1,352,013,000 | -19,880,000 | -19,164,000 | 1,817,293,000 | 957,876,000 | — | -11,553,000 |
TTM Snapshot
Revenues TTM
$1,707,472,000
NetIncome TTM
$-59,378,000
OpCashFlow TTM
$0
Assets (Latest)
$2,544,411,000
Forward EPS
$0.36
Max Pain — expiry 2026-08-21
max pain strike: $5.00 · spot: $3.09 · call oi: 2,251 · put oi: 2,489Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KTF | DWS MUNICIPAL INCOME TRUST | $345.90M | $8.83 | — |
| HIX | WESTERN ASSET HIGH INCOME FUND II INC. | $349.47M | $3.88 | — |
| DGMDF | Digital Domain Holdings Limited/ADR | $351.09M | $0.04 | — |
| JGH | Nuveen Global High Income Fund | $352.14M | $12.52 | — |
| HPF | JOHN HANCOCK PREFERRED INCOME FUND II | $342.95M | $15.84 | — |
News headlines (Yahoo Finance, 1h cache)
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
2026-07-31 19:55 · Yahoo
Tempus AI (TEM) Reports Q2 Loss, Beats Revenue Estimates
2026-07-30 21:25 · Yahoo
Philips Q2 Earnings and Revenues Increase Year over Year, Shares Down
2026-07-29 18:01 · Yahoo
Why Evolent Health (EVH) Stock Is Nosediving
2026-07-23 17:00 · Yahoo
Forget Nvidia. These 5 S&P 500 stocks are quietly going all in on AI.
2026-07-21 20:09 · Yahoo
3 Unprofitable Stocks with Questionable Fundamentals
2026-07-17 13:13 · Yahoo
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now
2026-07-16 19:00 · Yahoo
American Well (AMWL) Soars 11.1%: Is Further Upside Left in the Stock?
2026-07-14 11:54 · Yahoo
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026
2026-07-08 20:30 · Yahoo
Should You Buy Evolent Health (EVH) After Golden Cross?
2026-07-03 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.